Can a lobbying push led by veterans help MDMA get approved for PTSD treatment?

(By Will Stone for NPR)

Working in the music industry, Rogers Masson traveled in plenty of circles where ecstasy made an appearance, but he was never interested in taking the drug himself.

He was equally skeptical when his wife first mentioned that a nearby clinic was combining therapy and MDMA, the active ingredient in ecstasy, to treat post-traumatic stress disorder. Continue reading here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.